Australia's largest stock trading and investment forum Australia's #1 stock forum

IPH

1.81%

$5.06 iph limited

Talk about only seeing a glass-half-empty perspective! How much...

First 2 Last

Share
Profile

Follow
Serendipity

1,197 Posts.

3

10/03/16

12:30

Post #: 17237231
Share

Originally posted by Shiva100 ↑

I heard from a patent attorney about the effect of the TransTasman legislation. Australian patent attorney firms will lose the income from the New Zealand side of their practices, and New Zealand firms their Australian income.

I was told that for IPH Sprusons it may be 2% reduction in total revenue and possibly a 4% reduction in profit. For other firms it is likely to be much worse, 10% or higher as they have a greater proportion of New Zealand work as direct filings. Apparently the percentage can be worked out from conducting searches of the patent office databases.

Sprusons gets 70 to 80% of their income from patent filings, and most of that money comes from direct filings in Australia, New Zealand and Singapore. Although they may file in other jurisdictions those other filings use foreign agents who do most of the work.

Most of the profit from the direct filings is made at the filing stage as it is highly automated. Some profit is made during prosecution but there are higher operational costs due to the involvement of employee attorneys.

Once the Trans Tasman patent comes into operation, attorney firms will only file one patent application to cover Australia and New Zealand instead of two separate applications and there will be only one prosecution to grant instead of two. Patent owners will benefit from significantly reduced overall costs at the expense of the attorney firms.
The New Zealand practice of IPH Sprusons is a smaller percentage of their direct work so IPH Sprusons should be effected to a smaller amount than their other divisions such IPH Pizzeys or their listed competitor XenithIP or the privately owned firms.
The effect may be more than simply the loss of the profits from the New Zealand side of the business. The Australian and New Zealand marketplace is already competitive and when it happens it may trigger a price war as firms try to maintain profit ratios.

Expand

Talk about only seeing a glass-half-empty perspective! How much is the Australian and Asian marketplaces growing ATM? Who will win in a price competitive market - maybe the company with most scale and geographic diversity!

If you are considering IPH as an investment opportunity, you may wish to consider the positives as well and weigh them along with the negatives. Every company on the stock market would consider a potential price war as a threat.. Higher quality posts please!

IPH Price at posting: $7.15 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Chaos reigns markets – so let's take stock of where we're at ahead of December

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 50 more messages in this thread...

First 2 Last

Add IPH (ASX) to my watchlist

(20min delay)
Last $5.06		Change 0.090(1.81%)		Mkt cap ! $1.578B

Open	High	Low	Value	Volume
$5.02	$5.09	$5.01	$3.732M	737.8K

Buyers (Bids)

No.	Vol.	Price($)
1	3296	$5.05

Sellers (Offers)

Price($)	Vol.	No.
$5.06	3392	3

View Market Depth

No.	Vol.	Price($)
1	1335	5.980
6	25069	5.950
2	6370	5.940
1	3489	5.930
1	534	5.920

Price($)	Vol.	No.
5.990	2951	3
6.000	5688	3
6.010	8304	2
6.020	7870	3
6.030	16750	2

Last trade - 16.10pm 28/11/2024 (20 minute delay)

IPH (ASX) Chart

Talk about only seeing a glass-half-empty perspective! How much...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Chaos reigns markets – so let's take stock of where we're at ahead of December

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Buyers (Bids)

Sellers (Offers)